EUVIMEDEUVIMED entdecken
Übersichtsarbeit

SARS ‐ CoV ‐2: A Liver Brief

Youness Limami iD, Hicham Wahnou iD, Martin Ndayambaje iD, Soufyane Hba iD, Oumaima Chgari iD, Mounia Ammara iD, Riad El Kebbaj iD, Abdallah Naya iD, Mounia Oudghiri iD, Raphaël Emmanuel Duval iD

WIREs Mechanisms of Disease · 2025

DOI: 10.1002/wsbm.70005 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift WIREs Mechanisms of Disease, 2025. Verfasst von Youness Limami und 9 weiteren Autor:innen. Beteiligte Einrichtung: Sciences and Engineering of Biomedicals, Biophysics and Health Laboratory, Higher Institute of Health Sciences, Hassan First University, Settat, Moro…. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, Liver Diseases, Liver. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 235 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Coronavirus Disease 2019 (COVID‐19) pandemic, caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2), has revealed the virus's ability to induce multi‐organ damage, including significant liver injury. The molecular mechanisms of liver dysfunction in COVID‐19 patients are explored, focusing on direct viral infection, immune‐mediated damage, and the gut–liver axis. SARS‐CoV‐2 enters liver cells through the Angiotensin‐Converting Enzyme 2 (ACE2) and Transmembrane Serine Protease 2 (TMPRSS2) receptors, but alternative pathways, such as CD209/Dendritic Cell‐Specific Intercellular adhesion molecule‐3‐Grabbing Non‐integrin (DC‐SIGN) and AXL receptors, can also contribute to viral entry. Additionally, immune responses, particularly the cytokine storm, exacerbate liver inflammation, leading to hepatocyte damage. Pre‐existing liver conditions, such as metabolic‐associated fatty liver disease (MAFLD), alcohol‐related liver disease (ALD), and liver fibrosis, heighten the risk of severe outcomes in COVID‐19 patients. Post‐COVID‐19 liver complications, including fibrosis progression and persistent liver damage, have been reported, with emerging evidence suggesting chronic inflammation, viral persistence, and autoimmune reactions as potential contributors. Furthermore, Drug‐Induced Liver Injury (DILI) from COVID‐19 treatments remains a concern, highlighting the need for careful management. Consequently, understanding the interplay between SARS‐CoV‐2 and the liver is critical for improving patient outcomes and developing targeted therapies to mitigate liver‐related complications in both acute and Long COVID‐19 phases. This article is categorized under: Infectious Diseases > Molecular and Cellular Physiology

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19SARS-CoV-2Liver DiseasesLiverHumansAngiotensin-Converting Enzyme 2Virus Internalization

Stichwörter der Autor:innen

COVID‐19SARS‐CoV‐2liver diseases

Substanzen

Angiotensin-Converting Enzyme 2

Autor:innen und Institutionen

  • Sciences and Engineering of Biomedicals, Biophysics and Health Laboratory, Higher Institute of Health Sciences, Hassan First University, Settat, Morocco.
  • Laboratory of Immunology and Biodiversity, Faculty of Sciences Ain Chock, Hassan II University, Casablanca, Morocco.
  • Université de Lorraine, Nancy, France.

ORCID-Profile: Youness Limami, Hicham Wahnou, Martin Ndayambaje, Soufyane Hba, Oumaima Chgari, Mounia Ammara, Riad El Kebbaj, Abdallah Naya, Mounia Oudghiri, Raphaël Emmanuel Duval

Zitieren

APA

Limami, Y., Wahnou, H., Ndayambaje, M., Hba, S., Chgari, O., Ammara, M., El Kebbaj, R., Naya, A., Oudghiri, M., & Duval, R. E. (2025). SARS ‐ CoV ‐2: A Liver Brief. WIREs Mechanisms of Disease. https://doi.org/10.1002/wsbm.70005

Vancouver

Limami Y, Wahnou H, Ndayambaje M, Hba S, Chgari O, Ammara M, et al. SARS ‐ CoV ‐2: A Liver Brief. WIREs Mechanisms of Disease. 2025. doi:10.1002/wsbm.70005

BibTeX
@article{Limami2025,
  author = {Limami, Youness and Wahnou, Hicham and Ndayambaje, Martin and Hba, Soufyane and Chgari, Oumaima and Ammara, Mounia and El Kebbaj, Riad and Naya, Abdallah and Oudghiri, Mounia and Duval, Raphaël Emmanuel},
  title = {SARS ‐ CoV ‐2: A Liver Brief},
  journal = {WIREs Mechanisms of Disease},
  year = {2025},
  doi = {10.1002/wsbm.70005}
}
Kostenlos starten →